NYSE:USNA - USANA Health Sciences Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$119.00 +0.75 (+0.63 %)
(As of 05/21/2018 04:00 PM ET)
Previous Close$118.75
Today's Range$118.75 - $120.00
52-Week Range$52.80 - $119.00
Volume2,679 shs
Average Volume129,321 shs
Market Capitalization$2.86 billion
P/E Ratio29.51
Dividend YieldN/A
Beta0.76

About USANA Health Sciences (NYSE:USNA)

USANA Health Sciences logoUSANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensé?beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Receive USNA News and Ratings via Email

Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryPersonal Products
SectorMedical
SymbolNYSE:USNA
CUSIP90328M10
Phone801-954-7100

Debt

Debt-to-Equity RatioN/A
Current Ratio2.90
Quick Ratio2.36

Price-To-Earnings

Trailing P/E Ratio29.51
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.05 billion
Price / Sales2.75
Cash Flow$4.8811 per share
Price / Cash24.38
Book Value$15.14 per share
Price / Book7.86

Profitability

EPS (Most Recent Fiscal Year)$4.06
Net Income$62.53 million
Net Margins6.47%
Return on Equity27.92%
Return on Assets20.26%

Miscellaneous

Employees1,810
Outstanding Shares24,180,000

USANA Health Sciences (NYSE:USNA) Frequently Asked Questions

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences announced that its Board of Directors has approved a share repurchase plan on Wednesday, July 26th 2017, which authorizes the company to repurchase $64,600,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 46% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board of directors believes its stock is undervalued.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) released its quarterly earnings results on Tuesday, April, 24th. The company reported $1.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.05 by $0.14. The business had revenue of $292 million for the quarter, compared to analysts' expectations of $268.93 million. USANA Health Sciences had a return on equity of 27.92% and a net margin of 6.47%. The company's revenue was up 14.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.91 EPS. View USANA Health Sciences' Earnings History.

When is USANA Health Sciences' next earnings date?

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Monday, July, 23rd 2018. View Earnings Estimates for USANA Health Sciences.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences updated its FY18 earnings guidance on Tuesday, April, 24th. The company provided earnings per share (EPS) guidance of $4.25-4.55 for the period, compared to the Thomson Reuters consensus estimate of $4.37. The company issued revenue guidance of $1.13-1.17 billion, compared to the consensus revenue estimate of $1.12 billion.

What price target have analysts set for USNA?

2 equities research analysts have issued 1-year target prices for USANA Health Sciences' shares. Their forecasts range from $95.00 to $95.00. On average, they anticipate USANA Health Sciences' share price to reach $95.00 in the next year. View Analyst Ratings for USANA Health Sciences.

Who are some of USANA Health Sciences' key competitors?

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the folowing people:
  • Dr. Myron W. Wentz, Founder & Chairman (Age 77)
  • Mr. Kevin G. Guest, CEO & Director (Age 55)
  • Mr. Jim Brown, Pres & COO (Age 49)
  • Mr. James H. Bramble, Chief Legal Officer, Gen. Counsel & Corp. Sec. (Age 48)
  • Mr. Daniel A. Macuga Jr., Chief Communications & Marketing Officer (Age 48)

Has USANA Health Sciences been receiving favorable news coverage?

News stories about USNA stock have been trending somewhat positive on Monday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. USANA Health Sciences earned a news sentiment score of 0.09 on Accern's scale. They also assigned press coverage about the company an impact score of 47.37 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.45%), Dimensional Fund Advisors LP (3.23%), Schroder Investment Management Group (1.38%), Matarin Capital Management LLC (0.65%), Hood River Capital Management LLC (0.63%) and Russell Investments Group Ltd. (0.57%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, Dave Wentz, David Mulham Mulham, Deborah Woo, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones, Robert Auciaux and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.

Which major investors are selling USANA Health Sciences stock?

USNA stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, BNP Paribas Arbitrage SA, UBS Group AG, Hays Advisory LLC, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Guggenheim Capital LLC, Camarda Financial Advisors LLC and New York State Common Retirement Fund. Company insiders that have sold USANA Health Sciences company stock in the last year include Daniel A Macuga, David Mulham Mulham, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.

Which major investors are buying USANA Health Sciences stock?

USNA stock was bought by a variety of institutional investors in the last quarter, including Matarin Capital Management LLC, Hood River Capital Management LLC, BlackRock Inc., Russell Investments Group Ltd., Millennium Management LLC, Fort L.P., Schwab Charles Investment Management Inc. and Mackay Shields LLC. View Insider Buying and Selling for USANA Health Sciences.

How do I buy shares of USANA Health Sciences?

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $119.00.

How big of a company is USANA Health Sciences?

USANA Health Sciences has a market capitalization of $2.86 billion and generates $1.05 billion in revenue each year. The company earns $62.53 million in net income (profit) each year or $4.06 on an earnings per share basis. USANA Health Sciences employs 1,810 workers across the globe.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at 0.


MarketBeat Community Rating for USANA Health Sciences (USNA)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  156 (Vote Outperform)
Underperform Votes:  257 (Vote Underperform)
Total Votes:  413
MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe USNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USNA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

USANA Health Sciences (NYSE:USNA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for USANA Health Sciences in the last 12 months. Their average twelve-month price target is $95.00, suggesting that the stock has a possible downside of 20.17%. The high price target for USNA is $95.00 and the low price target for USNA is $95.00. There are currently 2 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.002.502.503.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $95.00$95.00$95.00$80.00
Price Target Upside: 20.17% downside24.26% upside24.26% upside29.14% upside

USANA Health Sciences (NYSE:USNA) Consensus Price Target History

Price Target History for USANA Health Sciences (NYSE:USNA)

USANA Health Sciences (NYSE:USNA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/23/2018Pivotal ResearchDowngradeBuy ➝ Hold$95.00HighView Rating Details
1/24/2018SidotiDowngradeBuy ➝ NeutralMediumView Rating Details
7/28/2016DA DavidsonBoost Price TargetNeutral$135.00 ➝ $150.00N/AView Rating Details
(Data available from 5/21/2016 forward)

Earnings

USANA Health Sciences (NYSE:USNA) Earnings History and Estimates Chart

Earnings by Quarter for USANA Health Sciences (NYSE:USNA)

USANA Health Sciences (NYSE:USNA) Earnings Estimates

Current Year EPS Consensus Estimate: $4.4 EPS

USANA Health Sciences (NYSE USNA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/23/2018$1.12N/AView Earnings Details
4/24/2018Q1 2018$1.05$1.19$268.93 million$292.00 millionViewN/AView Earnings Details
2/6/2018Q4 2017$1.00$1.11$258.67 million$273.11 millionViewN/AView Earnings Details
10/24/2017Q3 2017$0.91$1.02$259.52 million$261.77 millionViewN/AView Earnings Details
7/25/2017Q2 2017$1.06$0.98$273.61 million$257.10 millionViewN/AView Earnings Details
5/2/2017Q1 2017$0.92$0.91$255.32 millionViewListenView Earnings Details
2/7/2017Q416$0.94$0.87$253.52 million$252.90 millionViewListenView Earnings Details
10/25/2016Q316$2.13$2.40$263.37 million$254.22 millionViewListenView Earnings Details
7/26/2016Q2$2.05$2.07$256.66 million$258.50 millionViewListenView Earnings Details
5/3/2016Q116$1.81$1.77$244.05 million$240.45 millionViewListenView Earnings Details
2/9/2016Q415$2.00$1.83$250.82 million$232.60 millionViewListenView Earnings Details
11/3/2015Q315$1.76$1.92$230.79 million$233.30 millionViewListenView Earnings Details
8/4/2015Q215$1.60$1.92$211.86 million$233.20 millionViewListenView Earnings Details
5/5/2015Q1$1.30$1.50$198.21 million$219.40 millionViewListenView Earnings Details
2/10/2015Q414$1.93$1.65$219.10 million$227.90 millionViewListenView Earnings Details
10/28/2014Q314$1.37$1.47$190.50 million$191.90 millionViewListenView Earnings Details
7/29/2014Q214$1.50$1.36$198.30 million$188.30 millionViewListenView Earnings Details
4/29/2014Q114$1.30$1.15$185.85 million$182.40 millionViewListenView Earnings Details
2/5/2014Q413$1.22$1.41$175.53 million$186.30 millionViewListenView Earnings Details
10/23/2013Q313$1.14$1.16$172.40 million$173.70 millionViewListenView Earnings Details
7/23/2013Q2 2013$1.33$1.72$176.60 million$189.10 millionViewListenView Earnings Details
4/23/2013Q1 2013$1.16$1.28$171.77 million$169.10 millionViewListenView Earnings Details
2/5/2013Q4 2012$1.21$1.27$165.80 million$168.50 millionViewListenView Earnings Details
10/23/2012$1.06$1.18ViewN/AView Earnings Details
7/24/2012$0.92$1.11ViewN/AView Earnings Details
4/24/2012Q1 2012$0.35$0.45ViewN/AView Earnings Details
2/7/2012$0.86$0.87ViewN/AView Earnings Details
10/25/2011$0.76$0.81ViewN/AView Earnings Details
7/26/2011Q2 2011$0.40$0.44ViewN/AView Earnings Details
4/26/2011$0.66$0.70ViewN/AView Earnings Details
2/8/2011$0.84$0.75ViewN/AView Earnings Details
10/26/2010Q3 2010$0.32$0.40ViewN/AView Earnings Details
7/27/2010Q2 2010$0.31$0.34ViewN/AView Earnings Details
4/27/2010Q1 2010$0.25$0.31ViewN/AView Earnings Details
2/9/2010Q4 2009$0.30$0.33ViewN/AView Earnings Details
10/27/2009Q3 2009$0.25$0.25ViewN/AView Earnings Details
7/28/2009Q2 2009$0.23$0.29ViewN/AView Earnings Details
4/28/2009Q1 2009$0.20$0.22ViewN/AView Earnings Details
2/23/2009Q4 2008$0.28$0.28ViewN/AView Earnings Details
10/14/2008Q3 2008$0.30$0.25ViewN/AView Earnings Details
7/22/2008Q2 2008$0.31$0.31ViewN/AView Earnings Details
4/21/2008Q1 2008$0.23$0.23ViewN/AView Earnings Details
2/5/2008Q4 2007$0.34$0.33ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

USANA Health Sciences (NYSE:USNA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

USANA Health Sciences (NYSE USNA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 48.00%
Institutional Ownership Percentage: 48.85%
Insider Trading History for USANA Health Sciences (NYSE:USNA)
Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

USANA Health Sciences (NYSE USNA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/16/2018David Mulham MulhamInsiderSell14,733$113.03$1,665,270.9914,733View SEC Filing  
5/2/2018G Doug IiekkingCFOSell510$105.54$53,825.40View SEC Filing  
5/1/2018Global Ltd GullMajor ShareholderSell40,000$105.96$4,238,400.00View SEC Filing  
4/3/2018Global Ltd GullMajor ShareholderSell40,000$86.23$3,449,200.0011,214,053View SEC Filing  
3/12/2018Global Ltd GullMajor ShareholderSell67,464$80.84$5,453,789.7611,439,646View SEC Filing  
3/12/2018Myron W WentzDirectorSell228,000$81.10$18,490,800.00View SEC Filing  
3/9/2018Myron W WentzDirectorSell78,129$81.19$6,343,293.51View SEC Filing  
3/8/2018Global Ltd GullMajor ShareholderSell82,407$81.24$6,694,744.6811,439,646View SEC Filing  
3/8/2018Paul A JonesInsiderSell10,696$81.00$866,376.0010,696View SEC Filing  
3/7/2018G Doug IiekkingCFOSell2,423$81.05$196,384.152,423View SEC Filing  
3/2/2018Myron W WentzDirectorSell28,050$76.14$2,135,727.00View SEC Filing  
3/1/2018Global Ltd GullMajor ShareholderSell11,950$75.77$905,451.5011,550,103View SEC Filing  
2/15/2018Myron W WentzDirectorSell53,372$76.01$4,056,805.72View SEC Filing  
2/15/2018Walter NootInsiderSell3,075$77.00$236,775.003,075View SEC Filing  
2/14/2018Global Ltd GullMajor ShareholderSell34,205$75.70$2,589,318.5011,581,220View SEC Filing  
2/13/2018Myron W WentzDirectorSell28,405$75.39$2,141,452.95View SEC Filing  
2/12/2018Global Ltd GullMajor ShareholderSell10,287$75.39$775,536.9311,641,846View SEC Filing  
2/9/2018Global Ltd GullMajor ShareholderSell1,984$74.78$148,363.5211,641,846View SEC Filing  
2/6/2018Myron W WentzDirectorSell38,223$71.51$2,733,326.73View SEC Filing  
2/5/2018Global Ltd GullMajor ShareholderSell8,344$72.28$603,104.3211,682,053View SEC Filing  
2/2/2018Global Ltd GullMajor ShareholderSell2,753$74.24$204,382.7211,682,053View SEC Filing  
11/22/2017Global Ltd GullMajor ShareholderSell45,216$66.44$3,004,151.0411,694,053View SEC Filing  
11/21/2017Myron W WentzDirectorSell164,916$66.40$10,950,422.40View SEC Filing  
11/20/2017Global Ltd GullMajor ShareholderSell39,751$66.11$2,627,938.6111,896,290View SEC Filing  
11/17/2017Myron W WentzDirectorSell7,895$66.03$521,306.85View SEC Filing  
11/16/2017Global Ltd GullMajor ShareholderSell101,929$66.05$6,732,410.4511,996,192View SEC Filing  
11/15/2017Myron W WentzDirectorSell11,835$66.07$781,938.45View SEC Filing  
11/13/2017Global Ltd GullMajor ShareholderSell7,289$66.01$481,146.8911,996,192View SEC Filing  
11/13/2017Myron W WentzDirectorSell5,304$66.01$350,117.0412,011,418View SEC Filing  
11/9/2017Myron W WentzDirectorSell1,985$66.01$131,029.8512,011,418View SEC Filing  
11/2/2017Global Ltd GullMajor ShareholderSell43,292$65.25$2,824,803.0012,053,403View SEC Filing  
11/1/2017Myron W WentzDirectorSell17,107$65.42$1,119,139.94View SEC Filing  
10/30/2017Global Ltd GullMajor ShareholderSell93,443$67.08$6,268,156.4412,089,267View SEC Filing  
10/30/2017Myron W WentzDirectorSell21,209$66.11$1,402,126.99View SEC Filing  
10/26/2017Gilbert A FullerDirectorSell1,710$67.01$114,587.101,710View SEC Filing  
10/26/2017Global Ltd GullMajor ShareholderSell60,871$67.39$4,102,096.6912,089,267View SEC Filing  
10/3/2017Myron W WentzDirectorSell40,000$57.54$2,301,600.00View SEC Filing  
9/15/2017Myron W WentzDirectorSell28,788$57.19$1,646,385.72View SEC Filing  
9/14/2017Global Ltd GullMajor ShareholderSell79,294$57.61$4,568,127.3412,272,013View SEC Filing  
9/14/2017Myron W WentzDirectorSell34,226$57.51$1,968,337.26View SEC Filing  
9/5/2017Global Ltd GullMajor ShareholderSell40,000$58.41$2,336,400.0012,326,224View SEC Filing  
8/30/2017Daniel A MacugaInsiderSell11,992$59.00$707,528.0011,992View SEC Filing  
8/28/2017Daniel A MacugaInsiderSell5,751$60.00$345,060.002,077View SEC Filing  
8/23/2017Jim BrownCOOSell16,574$58.84$975,214.162,175View SEC Filing  
8/23/2017Kevin GuestInsiderSell29,934$59.01$1,766,405.3410,549View SEC Filing  
8/21/2017James BrambleInsiderSell18,298$57.01$1,043,168.9820,374View SEC Filing  
8/2/2017Global Ltd GullMajor ShareholderSell14,533$56.71$824,166.4312,352,753View SEC Filing  
8/2/2017Myron W WentzDirectorSell40,000$56.59$2,263,600.00View SEC Filing  
8/1/2017Global Ltd GullMajor ShareholderSell25,467$56.52$1,439,394.8412,352,753View SEC Filing  
7/31/2017Gilbert A FullerDirectorSell1,483$57.67$85,524.611,483View SEC Filing  
7/5/2017Myron W WentzDirectorSell40,000$64.15$2,566,000.00View SEC Filing  
6/2/2017Myron W WentzDirectorSell40,000$64.99$2,599,600.00View SEC Filing  
6/1/2017Paul A JonesInsiderSell9,851$64.50$635,389.506,020View SEC Filing  
5/11/2017Gilbert A FullerDirectorSell4,884$64.38$314,431.924,884View SEC Filing  
5/1/2017Myron W WentzDirectorSell40,000$56.39$2,255,600.00View SEC Filing  
4/5/2017Global Ltd GullMajor ShareholderSell16,436$56.54$929,291.4412,524,696View SEC Filing  
4/5/2017Myron W WentzDirectorSell40,000$56.81$2,272,400.00View SEC Filing  
4/4/2017Global Ltd GullMajor ShareholderSell10,040$56.69$569,167.6012,524,696View SEC Filing  
4/3/2017Global Ltd GullMajor ShareholderSell13,524$57.22$773,843.2812,524,696View SEC Filing  
3/8/2017Global Ltd GullMajor ShareholderSell20,000$57.15$1,143,000.0012,538,220View SEC Filing  
2/8/2017Global Ltd GullMajor ShareholderSell20,000$55.87$1,117,400.0012,558,220View SEC Filing  
1/11/2017Myron W WentzDirectorSell20,000$61.04$1,220,800.00View SEC Filing  
12/14/2016Myron W WentzDirectorSell20,000$61.41$1,228,200.00View SEC Filing  
11/9/2016Myron W WentzDirectorSell10,000$123.99$1,239,900.00View SEC Filing  
10/12/2016Global Ltd GullMajor ShareholderSell10,000$146.35$1,463,500.006,319,110View SEC Filing  
9/14/2016Global Ltd GullMajor ShareholderSell10,000$134.67$1,346,700.006,329,110View SEC Filing  
9/8/2016Deborah WooInsiderSell1,058$140.00$148,120.002,537View SEC Filing  
8/30/2016Paul A JonesCFOSell5,067$138.50$701,779.505,067View SEC Filing  
8/23/2016Deborah WooInsiderSell2,621$138.94$364,161.743,982View SEC Filing  
8/23/2016Robert AuciauxDirectorSell2,317$138.79$321,576.432,317View SEC Filing  
8/19/2016Deborah WooInsiderSell4,590$133.12$611,020.805,660View SEC Filing  
8/18/2016Deborah WooInsiderSell5,041$131.15$661,127.15View SEC Filing  
8/16/2016James BrambleInsiderSell9,339$131.33$1,226,490.872,482View SEC Filing  
8/16/2016Jim BrownCOOSell9,104$131.36$1,195,901.441,513View SEC Filing  
8/15/2016Kevin GuestInsiderSell16,285$131.08$2,134,637.8016,285View SEC Filing  
8/10/2016Global Ltd GullMajor ShareholderSell10,000$135.08$1,350,800.006,339,110View SEC Filing  
8/1/2016Gilbert A. FullerDirectorSell859$137.07$117,743.13View SEC Filing  
7/13/2016Global Ltd GullMajor ShareholderSell10,000$118.96$1,189,600.006,349,110View SEC Filing  
6/8/2016Global Ltd GullMajor ShareholderSell10,000$123.47$1,234,700.006,359,110View SEC Filing  
6/7/2016Dave WentzInsiderSell10,000$125.09$1,250,900.00388,615View SEC Filing  
5/11/2016Global Ltd GullMajor ShareholderSell10,000$122.67$1,226,700.006,369,110View SEC Filing  
4/13/2016Global Ltd GullMajor ShareholderSell10,000$121.82$1,218,200.006,379,110View SEC Filing  
3/9/2016Myron W WentzDirectorSell10,000$116.07$1,160,700.00View SEC Filing  
3/4/2016Jerry G McclainDirectorSell767$118.17$90,636.39767View SEC Filing  
2/24/2016Gilbert A FullerDirectorSell728$113.22$82,424.16728View SEC Filing  
2/10/2016Global Ltd GullMajor ShareholderSell10,000$96.37$963,700.006,399,110View SEC Filing  
1/13/2016Global Ltd GullMajor ShareholderSell10,000$121.04$1,210,400.006,409,110View SEC Filing  
12/17/2015Rick StambaughinsiderSell7,059$130.18$918,940.62View SEC Filing  
12/16/2015Doug BraunCMOSell10,907$130.80$1,426,635.60View SEC Filing  
12/15/2015Dave WentzInsiderSell6,000$130.59$783,540.00442,765View SEC Filing  
12/15/2015Doug BraunCMOSell2,748$132.00$362,736.00View SEC Filing  
12/9/2015Myron W WentzDirectorSell10,000$133.18$1,331,800.00View SEC Filing  
11/11/2015Global Ltd GullMajor ShareholderSell10,000$133.71$1,337,100.006,429,110View SEC Filing  
10/1/2015Myron W WentzDirectorSell10,000$131.85$1,318,500.00View SEC Filing  
9/10/2015Myron W WentzDirectorSell7,000$138.32$968,240.00View SEC Filing  
8/27/2015Deborah WooinsiderSell1,527$150.00$229,050.00View SEC Filing  
8/17/2015Paul A JonesCFOSell7,719$162.21$1,252,098.99View SEC Filing  
8/12/2015Myron W WentzDirectorSell7,000$159.84$1,118,880.00View SEC Filing  
7/8/2015Myron W WentzDirectorSell7,000$138.28$967,960.00View SEC Filing  
6/10/2015Myron W WentzDirectorSell7,000$133.75$936,250.00View SEC Filing  
6/9/2015Deborah WooInsiderSell3,656$132.06$482,811.36View SEC Filing  
5/14/2015Deborah WooInsiderSell3,569$124.00$442,556.00View SEC Filing  
5/12/2015Kevin GuestInsiderSell2,858$120.00$342,960.00View SEC Filing  
5/11/2015Daniel A MacugaInsiderSell4,231$125.64$531,582.84View SEC Filing  
5/11/2015Jim BrownCOOSell7,860$124.46$978,255.60View SEC Filing  
4/8/2015Global Ltd GullMajor ShareholderSell7,000$113.54$794,780.00View SEC Filing  
2/12/2015Robert AuciauxDirectorSell5,028$100.18$503,705.04View SEC Filing  
1/14/2015Myron W WentzDirectorSell7,000$101.32$709,240.00View SEC Filing  
12/16/2014Doug BraunCMOSell9,969$101.01$1,006,968.69View SEC Filing  
12/10/2014Myron W WentzDirectorSell102,755$100.25$10,301,188.75View SEC Filing  
12/8/2014Myron W WentzDirectorSell184,245$104.65$19,281,239.25View SEC Filing  
11/3/2014Dave WentzInsiderSell19,780$114.68$2,268,370.40View SEC Filing  
10/31/2014Ronald S PoelmanDirectorSell4,491$112.53$505,372.23View SEC Filing  
10/30/2014Paul A JonesCFOSell10,823$105.10$1,137,497.30View SEC Filing  
10/8/2014Myron W WentzDirectorSell7,000$76.52$535,640.00View SEC Filing  
9/10/2014Myron W WentzDirectorSell7,000$71.53$500,710.00View SEC Filing  
8/25/2014Dave WentzInsiderSell5,141$73.30$376,835.30View SEC Filing  
7/9/2014Myron W WentzDirectorSell7,000$78.95$552,650.00View SEC Filing  
6/13/2014Dave WentzInsiderSell5,301$75.51$400,278.51View SEC Filing  
6/11/2014Myron W WentzDirectorSell7,000$74.69$522,830.00View SEC Filing  
6/10/2014Daniel A MacugaInsiderSell6,654$75.01$499,116.54View SEC Filing  
5/30/2014Deborah WooInsiderSell1,028$73.00$75,044.00View SEC Filing  
5/28/2014Dave WentzInsiderSell5,141$73.03$375,447.23View SEC Filing  
5/28/2014Jerry G McclainDirectorSell1,217$72.12$87,770.04View SEC Filing  
5/22/2014Kevin GuestInsiderSell10,160$71.15$722,884.00View SEC Filing  
5/21/2014Kevin GuestInsiderSell2,475$71.00$175,725.00View SEC Filing  
5/19/2014James BrambleInsiderSell5,919$70.02$414,448.38View SEC Filing  
5/14/2014Myron WentzDirectorSell14,000$73.78$1,032,920.00View SEC Filing  
5/12/2014Deborah WooInsiderSell11,336$70.03$793,860.08View SEC Filing  
5/5/2014Deborah WooInsiderSell3,512$71.00$249,352.00View SEC Filing  
3/4/2014Myron WentzDirectorSell63,805$72.69$4,637,985.45View SEC Filing  
2/11/2014Doug BraunCMOSell8,139$70.46$573,473.94View SEC Filing  
11/13/2013Myron WentzDirectorSell7,000$67.68$473,760.00View SEC Filing  
10/9/2013Holdings Ltd Gullmajor shareholderSell7,000$80.08$560,560.006,581,167View SEC Filing  
9/11/2013Deborah WooInsiderSell1,340$79.01$105,873.40View SEC Filing  
9/11/2013Holdings Ltd Gullmajor shareholderSell7,000$78.19$547,330.006,588,167View SEC Filing  
9/5/2013Dave WentzInsiderSell13,704$77.93$1,067,952.72473,955View SEC Filing  
9/3/2013Dave WentzInsiderSell32,174$78.10$2,512,789.40473,955View SEC Filing  
8/14/2013Holdings Ltd Gullmajor shareholderSell7,000$80.34$562,380.006,595,167View SEC Filing  
8/1/2013Deborah WooInsiderSell1,386$85.00$117,810.00View SEC Filing  
7/26/2013Paul A JonesCFOSell5,047$78.01$393,716.47View SEC Filing  
7/25/2013Kevin GuestInsiderSell19,290$73.20$1,412,028.00View SEC Filing  
7/25/2013Ronald S PoelmanDirectorSell6,380$73.20$467,016.00View SEC Filing  
7/10/2013Holdings Ltd GullMajor ShareholderSell7,000$78.22$547,540.00View SEC Filing  
6/12/2013Holdings Ltd GullMajor ShareholderSell7,000$70.96$496,720.00View SEC Filing  
5/9/2013Robert AuciauxDirectorSell2,664$55.92$148,970.88View SEC Filing  
5/8/2013Holdings Ltd GullMajor ShareholderSell7,000$56.59$396,130.00View SEC Filing  
4/10/2013Holdings Ltd GullMajor ShareholderSell7,000$47.45$332,150.00View SEC Filing  
8/8/2012Myron W WentzDirectorSell7,000$44.21$309,470.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

USANA Health Sciences (NYSE USNA) News Headlines

Source:
DateHeadline
USANA Health Sciences (USNA) Insider David Mulham Mulham Sells 14,733 SharesUSANA Health Sciences (USNA) Insider David Mulham Mulham Sells 14,733 Shares
www.americanbankingnews.com - May 18 at 7:29 PM
Comparing ChromaDex (CDXC) and USANA Health Sciences (USNA)Comparing ChromaDex (CDXC) and USANA Health Sciences (USNA)
www.americanbankingnews.com - May 17 at 3:23 PM
Analyzing USANA Health Sciences (USNA) & ChromaDex (CDXC)Analyzing USANA Health Sciences (USNA) & ChromaDex (CDXC)
www.americanbankingnews.com - May 14 at 9:16 PM
Contrasting True Drinks (TRUU) and USANA Health Sciences (USNA)Contrasting True Drinks (TRUU) and USANA Health Sciences (USNA)
www.americanbankingnews.com - May 12 at 5:11 PM
Reviewing Stada Arzneimittel (STDAF) & USANA Health Sciences (USNA)Reviewing Stada Arzneimittel (STDAF) & USANA Health Sciences (USNA)
www.americanbankingnews.com - May 12 at 12:03 PM
ChromaDex (CDXC) & USANA Health Sciences (USNA) Head-To-Head ComparisonChromaDex (CDXC) & USANA Health Sciences (USNA) Head-To-Head Comparison
www.americanbankingnews.com - May 9 at 11:20 PM
USANA Manufacturing Facility Passes Rigorous AuditUSANA Manufacturing Facility Passes Rigorous Audit
finance.yahoo.com - May 7 at 9:35 AM
Todays Research Reports on Trending Tickers: Herbalife Nutrition and USANA Health SciencesToday's Research Reports on Trending Tickers: Herbalife Nutrition and USANA Health Sciences
finance.yahoo.com - May 4 at 9:39 AM
G Doug Iiekking Sells 510 Shares of USANA Health Sciences (USNA) StockG Doug Iiekking Sells 510 Shares of USANA Health Sciences (USNA) Stock
www.americanbankingnews.com - May 3 at 8:45 PM
Insider Selling: USANA Health Sciences (USNA) Major Shareholder Sells 40,000 Shares of StockInsider Selling: USANA Health Sciences (USNA) Major Shareholder Sells 40,000 Shares of Stock
www.americanbankingnews.com - May 3 at 7:33 PM
USANA Health Sciences (USNA) Rating Increased to Buy at ValuEngineUSANA Health Sciences (USNA) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - May 2 at 3:12 PM
Edited Transcript of USNA earnings conference call or presentation 25-Apr-18 3:00pm GMTEdited Transcript of USNA earnings conference call or presentation 25-Apr-18 3:00pm GMT
finance.yahoo.com - May 1 at 4:10 PM
Form 4 USANA HEALTH SCIENCES For: Apr 23 Filed by: FULLER GILBERT AForm 4 USANA HEALTH SCIENCES For: Apr 23 Filed by: FULLER GILBERT A
www.streetinsider.com - April 26 at 4:14 PM
BRIEF-Usana Health Sciences Q1 Earnings Per Share $1.19BRIEF-Usana Health Sciences Q1 Earnings Per Share $1.19
www.reuters.com - April 26 at 4:14 PM
USANAs (USNA) CEO Kevin Guest on Q1 2018 Results - Earnings Call TranscriptUSANA's (USNA) CEO Kevin Guest on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 26 at 9:33 AM
USANA Health Sciences (USNA) Raised to A- at TheStreetUSANA Health Sciences (USNA) Raised to A- at TheStreet
www.americanbankingnews.com - April 26 at 8:00 AM
At $96.05, Is USANA Health Sciences Inc (NYSE:USNA) A Buy?At $96.05, Is USANA Health Sciences Inc (NYSE:USNA) A Buy?
finance.yahoo.com - April 25 at 4:23 PM
USANA Health Sciences (USNA) Announces  Earnings ResultsUSANA Health Sciences (USNA) Announces Earnings Results
www.americanbankingnews.com - April 25 at 1:24 PM
USANA Health Sciences Profit Climbs In Q1USANA Health Sciences Profit Climbs In Q1
www.nasdaq.com - April 25 at 9:57 AM
USANA Health: 1Q Earnings SnapshotUSANA Health: 1Q Earnings Snapshot
finance.yahoo.com - April 25 at 9:57 AM
USANA Health Sciences (USNA) Releases FY18 Earnings GuidanceUSANA Health Sciences (USNA) Releases FY18 Earnings Guidance
www.americanbankingnews.com - April 24 at 5:02 PM
USANA Health Sciences Reports Record First Quarter 2018 Net Sales and Increases 2018 OutlookUSANA Health Sciences Reports Record First Quarter 2018 Net Sales and Increases 2018 Outlook
finance.yahoo.com - April 24 at 4:24 PM
USANA Health Sciences (USNA) Downgraded by Pivotal ResearchUSANA Health Sciences (USNA) Downgraded by Pivotal Research
www.americanbankingnews.com - April 23 at 10:22 AM
USANA Health Sciences (USNA) Set to Announce Earnings on MondayUSANA Health Sciences (USNA) Set to Announce Earnings on Monday
www.americanbankingnews.com - April 23 at 4:28 AM
USANA Health Sciences (USNA) & ChromaDex (CDXC) Head-To-Head ContrastUSANA Health Sciences (USNA) & ChromaDex (CDXC) Head-To-Head Contrast
www.americanbankingnews.com - April 19 at 5:40 AM
MediWound (MDWD) and USANA Health Sciences (USNA) Head-To-Head SurveyMediWound (MDWD) and USANA Health Sciences (USNA) Head-To-Head Survey
www.americanbankingnews.com - April 9 at 7:14 AM
Comparing USANA Health Sciences (USNA) & Foamix Pharmaceuticals (FOMX)Comparing USANA Health Sciences (USNA) & Foamix Pharmaceuticals (FOMX)
www.americanbankingnews.com - April 8 at 1:16 AM
USANA Health Sciences (USNA) Lifted to "Sell" at BidaskClubUSANA Health Sciences (USNA) Lifted to "Sell" at BidaskClub
www.americanbankingnews.com - April 7 at 3:21 PM
Head to Head Review: MediWound (MDWD) & USANA Health Sciences (USNA)Head to Head Review: MediWound (MDWD) & USANA Health Sciences (USNA)
www.americanbankingnews.com - April 6 at 9:07 PM
USANA Health Sciences (USNA) Upgraded at BidaskClubUSANA Health Sciences (USNA) Upgraded at BidaskClub
www.americanbankingnews.com - April 4 at 11:26 PM
USANA Health Sciences, Inc. (USNA) Major Shareholder Global Ltd Gull Sells 40,000 SharesUSANA Health Sciences, Inc. (USNA) Major Shareholder Global Ltd Gull Sells 40,000 Shares
www.americanbankingnews.com - April 4 at 10:22 PM
USANA Health Sciences (USNA) Downgraded by BidaskClub to SellUSANA Health Sciences (USNA) Downgraded by BidaskClub to Sell
www.americanbankingnews.com - April 2 at 9:34 AM
Insider Selling: USANA Health Sciences, Inc. (USNA) Insider Sells 10,696 Shares of StockInsider Selling: USANA Health Sciences, Inc. (USNA) Insider Sells 10,696 Shares of Stock
www.americanbankingnews.com - March 12 at 7:39 PM
Myron W. Wentz Sells 78,129 Shares of USANA Health Sciences, Inc. (USNA) StockMyron W. Wentz Sells 78,129 Shares of USANA Health Sciences, Inc. (USNA) Stock
www.americanbankingnews.com - March 12 at 7:22 PM
USANA Health Sciences, Inc. (USNA) Major Shareholder Sells $5,453,789.76 in StockUSANA Health Sciences, Inc. (USNA) Major Shareholder Sells $5,453,789.76 in Stock
www.americanbankingnews.com - March 12 at 7:22 PM
USANA Health Sciences, Inc. (USNA) Major Shareholder Global Ltd Gull Sells 82,407 SharesUSANA Health Sciences, Inc. (USNA) Major Shareholder Global Ltd Gull Sells 82,407 Shares
www.americanbankingnews.com - March 12 at 7:21 PM
Insider Selling: USANA Health Sciences, Inc. (USNA) Director Sells 228,000 Shares of StockInsider Selling: USANA Health Sciences, Inc. (USNA) Director Sells 228,000 Shares of Stock
www.americanbankingnews.com - March 12 at 7:20 PM
USANA Named Top Rated Direct Selling Brand for Fifth TimeUSANA Named Top Rated Direct Selling Brand for Fifth Time
finance.yahoo.com - March 12 at 10:24 AM
Insider Selling: USANA Health Sciences, Inc. (USNA) CFO Sells 2,423 Shares of StockInsider Selling: USANA Health Sciences, Inc. (USNA) CFO Sells 2,423 Shares of Stock
www.americanbankingnews.com - March 8 at 12:31 AM
Form 4 USANA HEALTH SCIENCES For: Mar 01 Filed by: Gull Global LtdForm 4 USANA HEALTH SCIENCES For: Mar 01 Filed by: Gull Global Ltd
www.streetinsider.com - March 6 at 9:40 AM
Global Ltd Gull Sells 11,950 Shares of USANA Health Sciences, Inc. (USNA) StockGlobal Ltd Gull Sells 11,950 Shares of USANA Health Sciences, Inc. (USNA) Stock
www.americanbankingnews.com - March 5 at 9:11 PM
USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 28,050 SharesUSANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 28,050 Shares
www.americanbankingnews.com - March 5 at 9:10 PM
Martingale Asset Management L P Has $2.59 Million Stake in USANA Health Sciences, Inc. (USNA)Martingale Asset Management L P Has $2.59 Million Stake in USANA Health Sciences, Inc. (USNA)
www.americanbankingnews.com - March 3 at 11:50 AM
Arrowstreet Capital Limited Partnership Purchases 70,917 Shares of USANA Health Sciences, Inc. (USNA)Arrowstreet Capital Limited Partnership Purchases 70,917 Shares of USANA Health Sciences, Inc. (USNA)
www.americanbankingnews.com - March 2 at 5:04 AM
Usana Health Sciences Inc (USNA) Files 10-K for the Fiscal Year Ended on December 31, 2017Usana Health Sciences Inc (USNA) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 28 at 4:43 PM
USANA Health Sciences, Inc. (USNA) Holdings Boosted by Fort L.P.USANA Health Sciences, Inc. (USNA) Holdings Boosted by Fort L.P.
www.americanbankingnews.com - February 27 at 3:37 PM
Herbalife’s 4Q17 Sales Beat Estimate, Returned to GrowthHerbalife’s 4Q17 Sales Beat Estimate, Returned to Growth
finance.yahoo.com - February 23 at 4:38 PM
Herbalife Crushed 4Q17 Earnings Estimate, Marking 29% GrowthHerbalife Crushed 4Q17 Earnings Estimate, Marking 29% Growth
finance.yahoo.com - February 23 at 4:38 PM
Why Herbalife Stock Fell despite Strong 4Q17 ResultsWhy Herbalife Stock Fell despite Strong 4Q17 Results
finance.yahoo.com - February 23 at 4:38 PM
Insider Selling: USANA Health Sciences, Inc. (USNA) Director Sells 53,372 Shares of StockInsider Selling: USANA Health Sciences, Inc. (USNA) Director Sells 53,372 Shares of Stock
www.americanbankingnews.com - February 16 at 9:10 PM

SEC Filings

USANA Health Sciences (NYSE:USNA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

USANA Health Sciences (NYSE:USNA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

USANA Health Sciences (NYSE USNA) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.